Previous close | 185.05 |
Open | 179.65 |
Bid | 178.80 x 0 |
Ask | 179.25 x 0 |
Day's range | 179.65 - 179.65 |
52-week range | 179.65 - 304.00 |
Volume | |
Avg. volume | 4 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A closer look at one of the leaders in the global multiple sclerosis therapeutics market